LOS ANGELES, Oct. 16, 2026 /PRNewswire/ — Westcove Partners, LLC (“Westcove”), a highly specialized investment bank, announced that it acted as the exclusive financial advisor to Clinical Research of West Florida (“CRWF”) in its partnership with Fengate Private Equity, a division of Fengate Asset Management (“Fengate”). The terms of the transaction were not disclosed. Westcove’s deal team included Justin Hand, Managing Director; Abe M’Bodj, Managing Director; Bill Bolding, Director; Geno Catalano, Vice President; and Andrew Hartono, Associate.

Clinical Research of West Florida is a leading independent clinical research platform operating three Phase I–IV facilities across the Tampa Bay area. Founded in 1995, CRWF has conducted 1,000+ trials across a broad range of therapeutic areas, with differentiated expertise in complex autoimmune and rheumatology indications. The Company’s experienced investigator base, proprietary patient database, and preferred relationships with leading sponsors and CROs have established CRWF as a trusted partner for high-quality trial execution and patient enrollment.

Aydin Keskiner, Owner and President of Clinical Research of West Florida, commented, “Westcove was unquestionably the right partner for us. Their understanding of our business and the clinical research industry as a whole, was evident throughout the process. From the outset, we felt they always had our back and were fully invested in achieving the best outcome for our company and team. Most importantly, they recognized the value of the organization we had built and what mattered most to us in a partner. We are very excited to partner with Fengate and continue building CRWF into a leading clinical research platform.”

Bill Bolding, Director of Westcove, commented, “CRWF has all the core attributes of a quality clinical research platform. Aydin and the team have a clear vision for expanding that model across new markets and therapeutic areas, and Fengate brings the resources and experience to help accelerate that growth. We are excited to see CRWF enter its next chapter with a partner so closely aligned with its strategic objectives.”

About Clinical Research of West Florida
Clinical Research of West Florida is an independent clinical research organization serving the Tampa Bay area for more than 30 years. The Company conducts Phase I–IV clinical trials across a diverse range of therapeutic areas, with particular expertise in complex autoimmune and rheumatology indications. CRWF works with leading pharmaceutical sponsors and CROs to advance the development of new therapies through high-quality clinical execution and patient-centered care. For more information, visit www.crwf.com.

About Fengate Private Equity 
Fengate Asset Management is a leading alternative investment manager, with more than $20 billion in assets under management, focused on private equity, infrastructure and real estate strategies. With offices and team members across Canada and the United States, Fengate leverages more than 50 years of entrepreneurial experience to deliver excellent investment results on behalf of its clients. Fengate Private Equity, a division of Fengate Asset Management, is a differentiated investment platform supporting the growth ambitions of entrepreneurs through transformative capital.  For more information, visit www.fengate.com.

About Westcove Partners
Westcove Partners is a premier healthcare-focused investment bank specializing in mergers and acquisitions, debt and equity financings, and other complex corporate finance transactions. The firm is dedicated to advising founder-operated businesses, tailoring its advisory services to address the unique challenges and opportunities these businesses face. For more information, visit www.westcove.com.

Contact:
Andrew Hartono, ahartono@westcove.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/westcove-advises-clinical-research-of-west-florida-in-its-partnership-with-fengate-private-equity-302910408.html

SOURCE Westcove Partners, LLC